Exclusive

Publication

Byline

Location

The Great Pharma Pivot- How India's pharma strategy reversed and why 2026 forced its hand

India, Aug. 1 -- image credit- shutterstock When Sun Pharmaceutical Industries agreed in April 2026 to acquire New Jersey-based Organon & Co. for $11.75 billion - $14.00 a share, all cash - the cover... Read More


Cancer Drug Shortage Puts Treatment at Risk as India Balances Affordability and Supply

India, Aug. 1 -- image credit- freepik The National Pharmaceutical Pricing Authority (NPPA) took an unusual but significant step on June 12, 2026, by increasing the ceiling prices of the chemotherapy... Read More


Why Drug Safety Has Become India's Next Pharmaceutical Imperative

India, Aug. 1 -- image credit- freepik Drug safety has come under renewed scrutiny as regulators in India and overseas step up surveillance beyond manufacturing compliance. Within weeks, Lupin's reca... Read More


"IPC continues to strengthen pharmacovigilance through the adoption of digital technologies"

India, Aug. 1 -- How does IPC ensure that medicines marketed in India meet the required standards of quality, safety, and efficacy? The Indian Pharmacopoeia Commission (IPC), an autonomous institutio... Read More


How AI, Multi-Omics and Biologics Are Rewriting the Future of Mass Spectrometry

India, Aug. 1 -- Not long ago, mass spectrometry was regarded as a highly specialised technology found primarily in elite research laboratories and pharmaceutical R&D centres. Today, it is quietly bec... Read More


"Healthcare infrastructure should never be planned in phases dictated by financial uncertainty"

India, Aug. 1 -- As HOSMAC completes 30 years, what healthcare infrastructure gap did you identify in 1996 that led to the company's founding, and how relevant is that gap today? When I was working a... Read More


"Structural challenges have slowed the growth of the Indian MedTech ecosystem"

India, Aug. 1 -- Can you share how the partnership with CfHE at IIT Hyderabad will support the development and commercialisation of next-generation healthcare technologies? Silicon Labs has entered i... Read More


Why the Future of Life Sciences Will Be Won Through Supply Chains, Not Factories

India, Aug. 1 -- Scale, efficiency, and cost optimisation were the deciding factors for competitiveness in the global life sciences industry for decades. However, in an era shaped by geopolitical tens... Read More


Why M&A is becoming core growth lever for emerging healthcare companies

India, Aug. 1 -- India's healthcare and life sciences sector is entering a new phase of growth. Emerging healthcare companies are increasingly employing acquisitions as a business strategy to expand f... Read More


From Precision to Prediction: Decentralising, Digitising, and Democratising Diagnostics

India, Aug. 1 -- Diagnostics is moving beyond a single test result in the patient journey to becoming an ongoing intelligence layer across the care continuum. The goal is no longer only to diagnose di... Read More